On the other hand, FETUA (AHSG, alpha 2-HS glycoprotein), a plasma glycoprotein predominantly synthesized in the liver, is increased in type 2 diabetes mellitus, metabolic syndrome, and nonalcoholic fatty liver disorder (NAFLD) (Bourebaba and Marycz, 2019). Here, AHSG is linked to metabolic dysfunction-associated steatotic liver disease.